Novus Therapeutics Inc (NVUS):製薬・医療:M&Aディール及び事業提携情報

【英語タイトル】Novus Therapeutics Inc (NVUS) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

GlobalDataが出版した調査資料(DATA904C7565)・商品コード:DATA904C7565
・発行会社(調査会社):GlobalData
・発行日:2018年10月
・ページ数:38
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール
・産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
【レポートの概要】

Summary
Novus Therapeutics Inc (Tokai Pharma), formerly Tokai Pharmaceuticals Inc is a pharmaceutical company that develops products for ear, nose and throat. The company’s lead products is a nasally-administer, combination drug product and eustachian tube dysfunction, among others. Its galeterone is an oral small molecule drug candidate with treatment of patients with metastatic castration-resistant prostate cancer. Novus Therapeutics offers OP-02 surfactant program and OP-01 foam platform. Its pipeline also includes androgen receptor degradation agent’s drug discovery program to identify and develop compounds for androgen receptor degradation activity. The company develops treatments for illnesses and disorders of the ears, nose, and throat. It has collaboration with pharmaceutical companies to enhance its product candidates. Novus Therapeutics is headquartered in Irvine, California, the US.

Novus Therapeutics Inc (NVUS) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Novus Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Novus Therapeutics Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Novus Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Novus Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Novus Therapeutics Inc, Medical Devices Deals, 2012 to YTD 2018 9
Novus Therapeutics Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Novus Therapeutics Inc, Pharmaceuticals & Healthcare, Deal Details 11
Venture Financing 11
Tokai Pharma Raises US$35.5 Million In Series E Financing 11
Partnerships 13
Tokai Pharma Expands Agreement with Qiagen 13
Tokai Pharma Expands Agreement with Qiagen 14
Licensing Agreements 15
Otic Pharma Enters into Licensing Agreement with Otodyne 15
Tokai Pharma Enters into Licensing Agreement with Johns Hopkins University 16
Tokai Pharma Amends Licensing Agreement with University of Maryland, Baltimore 17
Equity Offering 18
Novus Therapeutics Postpones Public Offering of Shares 18
Novus Therapeutics Plans to Raise up to USD150 Million in Public Offering of Securities 20
Novus Therapeutics Plans to Raise up to USD8.5 Million in Public Offering of Shares 21
Novus Therapeutics Files Registration Statement to Raise Funds through Public Offering of Shares 22
Tokai Pharma Raises USD0.71 Million in Public Offering of Shares 23
Tokai Pharma Raises USD97.2 Million in IPO 24
Acquisition 26
Tokai Pharma Acquires Otic Pharma 26
Novus Therapeutics Inc – Key Competitors 28
Novus Therapeutics Inc – Key Employees 29
Novus Therapeutics Inc – Locations And Subsidiaries 30
Head Office 30
Other Locations & Subsidiaries 30
Recent Developments 31
Financial Announcements 31
Aug 07, 2018: Novus Therapeutics Reports Second Quarter 2018 Financial Results 31
May 11, 2018: Novus Therapeutics Reports First Quarter 2018 Financial Results 32
Apr 02, 2018: Novus Therapeutics Reports Fourth Quarter and Full-Year 2017 Financial Results and Provides Corporate Update 33
Nov 08, 2017: Novus Therapeutics Reports Third Quarter 2017 Results 34
Aug 09, 2017: Novus Therapeutics Reports Second Quarter 2017 Results 35
Corporate Communications 36
Nov 06, 2017: Novus Therapeutics Announces the Promotion of Dr. Catherine Turkel to President 36
Jun 12, 2017: Novus Therapeutics Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) 37
Appendix 38
Methodology 38
About GlobalData 38
Contact Us 38
Disclaimer 38

List of Tables
Novus Therapeutics Inc, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Novus Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Novus Therapeutics Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Novus Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Novus Therapeutics Inc, Deals By Therapy Area, 2012 to YTD 2018 8
Novus Therapeutics Inc, Medical Devices Deals, 2012 to YTD 2018 9
Novus Therapeutics Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Tokai Pharma Raises US$35.5 Million In Series E Financing 11
Tokai Pharma Expands Agreement with Qiagen 13
Tokai Pharma Expands Agreement with Qiagen 14
Otic Pharma Enters into Licensing Agreement with Otodyne 15
Tokai Pharma Enters into Licensing Agreement with Johns Hopkins University 16
Tokai Pharma Amends Licensing Agreement with University of Maryland, Baltimore 17
Novus Therapeutics Postpones Public Offering of Shares 18
Novus Therapeutics Plans to Raise up to USD150 Million in Public Offering of Securities 20
Novus Therapeutics Plans to Raise up to USD8.5 Million in Public Offering of Shares 21
Novus Therapeutics Files Registration Statement to Raise Funds through Public Offering of Shares 22
Tokai Pharma Raises USD0.71 Million in Public Offering of Shares 23
Tokai Pharma Raises USD97.2 Million in IPO 24
Tokai Pharma Acquires Otic Pharma 26
Novus Therapeutics Inc, Key Competitors 28
Novus Therapeutics Inc, Key Employees 29
Novus Therapeutics Inc, Subsidiaries 30

List of Figures
Novus Therapeutics Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Novus Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Novus Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Novus Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Novus Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Novus Therapeutics Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Novus Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Novus Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Novus Therapeutics Inc, Medical Devices Deals, 2012 to YTD 2018 9

★調査レポート[Novus Therapeutics Inc (NVUS):製薬・医療:M&Aディール及び事業提携情報] (コード:DATA904C7565)販売に関する免責事項を必ずご確認ください。
★調査レポート[Novus Therapeutics Inc (NVUS):製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆